Stepping into a clinical trial supply lead role demands ownership, risk foresight, and agile forecasting to keep investigational product moving and patients on track.
- Active Versus Passive Shipping Solutions For Clinical Shipments
- Managing Risk And Resilience In Clinical Trial Supply And Operations
- FDA Staffing Constraints And Operational Risk In Clinical Supply
- Tariffs Threaten Clinical Trial Supply Chains: Preparing For Volatility
- The Key Role Of Clinical Supply Teams In Patient Centricity Efforts
- How Clinical Supply Teams Pull Better Demand Signals
- Why Clinical Supply Risk Starts With Demand Signals
- Clinical Supply Planning In A More Volatile And Regionalized World
ON-DEMAND WEBINARS
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
Discover how flexible, site-focused monitoring strategies are transforming clinical trials by improving communication, enhancing compliance, and resolving challenges before they impact study success.
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-155372946-cold-chain-cryopreservation-logistics]( "Ensuring On-Time Release Of CAR-T Cell Treatment In Spain")
Ensuring On-Time Release Of CAR-T Cell Treatment In SpainDue to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
![GettyImages-1266357505-vaccine-development-lab]( "How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs")
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial NeedsWhen selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
![trends-for-2025-GettyImages-2161094939]( "Outlook 2025: Key Trends & Insights")
Outlook 2025: Key Trends & InsightsDive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
![GettyImages-1404941712-Capsules_Blister_Packaging]( "Gain Confidence In Clinical Trial Outcomes")
Gain Confidence In Clinical Trial OutcomesDelve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
![Panademic Related Manufacturing Complications]( "Outsourcers Are Feeling Uneasy About Continuity Of Supply")
Outsourcers Are Feeling Uneasy About Continuity Of SupplyFind out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch")
Tech Transfer Strategies For mAb Drug Products In Late-Phase LaunchTech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
![GettyImages-1309776464-medical-research-analysis-lab-computer]( "IRT: A New Approach To Meeting The Needs Of Early Phase Trials")
IRT: A New Approach To Meeting The Needs Of Early Phase TrialsAs early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking]( "The Dual Sourcing Approach")
The Dual Sourcing ApproachHaving a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
![Computer analytics, planning-GettyImages-1473508663]( "Data Analytics For Better ClinRO Quality")
Data Analytics For Better ClinRO QualityMany trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
